EANM/SNMMI practice guideline for [<sup>18</sup>F]FDG PET/CT external beam radiotherapy treatment planning in uterine cervical cancer v1.0.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 33275178.
- Also identified by DOI 10.1007/s00259-020-05112-2 and PMC identifier 8041686.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The aim of this EANM / SNMMI Practice Guideline with ESTRO endorsement is to provide general information and specific considerations about [<sup>18</sup>F]FDG PET/CT in advanced uterine cervical cancer for external beam radiotherapy planning with emphasis on staging and target definition, mostly in FIGO stages IB3-IVA and IVB, treated with curative intention. Guidelines from related fields, relevant literature and leading experts have been consulted during the development of this guideline. As this field is rapidly evolving, this guideline cannot be seen as definitive, nor is it a summary of all existing protocols. Local variations should be taken into consideration when applying this guideline. The background, common clinical indications, qualifications and responsibilities of personnel, procedure / specifications of the examination, documentation / reporting and equipment specifications, quality control and radiation safety in imaging is discussed with an emphasis on the multidisciplinary approach.
Medical subject headings
- Fluorodeoxyglucose F18
- Uterine Cervical Neoplasms